Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

RNXT
RenovoRx, Inc. Common Stock
stock NASDAQ

Market Open
Aug 11, 2026 3:01:04 PM EDT
1.16USD0.000%(0.00)262,346
0.9700Bid   1.34Ask   0.37Spread
Pre-market
Aug 11, 2026 9:15:30 AM EDT
1.17USD+0.716%(+0.01)10,160
After-hours
Aug 10, 2026 4:59:30 PM EDT
1.05USD-9.483%(-0.11)0
OverviewHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 19, 2022
08:00AM EST  RenovoRx Announces Presentation at the 2022 SPECTRUM Conference Highlighting Its Innovative RenovoTAMP(tm) Therapy for Targeted Treatment of Cancer   Business Wire
Jan 6, 2022
08:00AM EST  RenovoRx to Present at the H.C. Wainwright Bioconnect Virtual Conference   Business Wire
Jan 5, 2022
11:07AM EST  Stocks That Hit 52-Week Lows On Wednesday   Benzinga
Nov 15, 2021
05:02PM EST  RenovoRx Reports Q3 Net Loss $1.5M Compared To A Net Loss Of $1.1M YoY   Benzinga
04:15PM EST  RenovoRx Announces Third Quarter 2021 Financial Results   Business Wire
Nov 11, 2021
06:08AM EST  RenovoRx To Present Final Data From RR2 Observational Registry Study At 2021 Pancreas Club Annual Meeting   RTTNews
06:08AM EST  RenovoRx Announced Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting; Study Results Validate Potential for Intra-arterial Chemotherapy Delivery for the Treatment of Pancreatic Cancer   Benzinga
06:00AM EST  RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting   Business Wire
Nov 10, 2021
02:30PM EST  Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; PubMatic Shares Gain After Q3 Results   Benzinga
12:11PM EST  Mid-Day Market Update: Gold Rises 1.5%; Poshmark Shares Drop   Benzinga
12:04PM EST  Shares of RenovoRx, Inc. (RNXT) are currently surging nearly 67% on Wednesday morning. RNXT is currently trading at $9.04, up $3.63 or 67.10%, on the Nasdaq.   RTTNews
10:11AM EST  Mid-Morning Market Update: Markets Edge Lower; US Inflation Rate Increases To 6.2%   Benzinga
05:29AM EST  Shares of RenovoRx Up 136% Premarket; Co on Tuesday Evening Made a Presentation on Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer   Benzinga
Nov 9, 2021
06:00AM EST  Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer   Business Wire
Nov 1, 2021
11:50AM EDT  Roth Capital Initiates Coverage On RenovoRx with Buy Rating, Announces Price Target of $16   Benzinga
Oct 6, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2021   Benzinga
08:25AM EDT  Maxim Group Initiates Coverage On RenovoRx with Buy Rating, Announces Price Target of $15   Benzinga
07:33AM EDT  The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal   Benzinga
Oct 5, 2021
08:01AM EDT  The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout   Benzinga
Oct 1, 2021
07:56AM EDT  The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO   Benzinga
Sep 30, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 29, 2021
08:13AM EDT  The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug   Benzinga
Sep 7, 2021
02:32PM EDT  Mid-Afternoon Market Update: Dow Falls Over 200 Points; RenovoRx Shares Spike Higher   Benzinga
12:12PM EDT  Mid-Day Market Update: Gold Drops 2%; Pliant Therapeutics Shares Jump   Benzinga
08:51AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Sept. 7, 2021: PLAY, SPOT, MTCH, BMRN, RNXT   Benzinga
06:33AM EDT  RenovoRx Gets New 510(k) Clearance For RenovoCath Delivery   RTTNews
06:08AM EDT  RenovoRx Receives New 510(k) Clearance For Its RenovoCath Delivery System Designed For Targeted Treatment Of Solid Tumors   Benzinga
06:06AM EDT  RenovoRx Gets New 510(k) Clearance From FDA For RenovoCath Delivery System For Solid Tumors   RTTNews
06:01AM EDT  RenovoRx Receives New 510(k) Clearance for its RenovoCath(r) Delivery System   PR Newswire
Sep 1, 2021
06:07AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.45 A.M. EDT).   RTTNews
Aug 31, 2021
08:15AM EDT  The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical   Benzinga
Aug 30, 2021
03:54PM EDT  Why RenovoRx Stock Is Trading Higher Today   Benzinga
Aug 29, 2021
09:48AM EDT  The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week   Benzinga
Aug 27, 2021
06:44AM EDT  The following are some of the stocks making big moves in Friday's pre-market trading (as of 6.17 A.M. EDT).   RTTNews
Aug 26, 2021
02:48PM EDT  Mid-Afternoon Market Update: Pure Storage Rises Following Strong Q2 Results; SelectQuote Shares Plunge   Benzinga
12:13PM EDT  Mid-Day Market Update: Dow Tumbles Over 100 Points; Ascendis Pharma Shares Spike Higher   Benzinga
10:26AM EDT  RenovoRx Shares Open For Trade At $8.25; IPO Priced At $9/Unit   Benzinga
09:09AM EDT  RenovoRx Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $9/Unit   Benzinga
08:09AM EDT  The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO   Benzinga
Aug 15, 2021
12:16PM EDT  The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow   Benzinga
11:06AM EDT  The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow   Benzinga
Aug 8, 2021
05:29PM EDT  IPO Previews For The Week   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC